Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
In this week’s Pathways Picks: CMS rolls out an AI-enabled prior authorization program in six states to curb “wasteful” device use, and adds reimbursement support for patients to upgrade diabetes devices; FDA publishes updated cybersecurity guide; South Korea revises its innovative device guidance; the UK plans funding guarantees for medtech; and more global policy updates.
A controversial set of papers in The British Medical Journal challenging the efficacy of common interventions for chronic low back pain reflects glaring gaps in treatment of a condition that affects millions, but industry has yet to commit substantial resources to addressing the underlying problems.
A comprehensive analysis of US spending on healthcare by condition aims to provide a more accurate assessment of US spending per disease, with potential to inform policy, industry, insurers, and other stakeholders. Excerpted from our recent MTS feature, Type 2 Diabetes, Dental, MSK Top US Healthcare Spending.